Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss

Abstract

Elevated osteoclast (OC) activity is a major contributor to inflammatory bone loss (IBL) during chronic inflammatory diseases. However, the specific OC precursors (OCPs) responding to inflammatory cues and the underlying mechanisms leading to IBL are poorly understood. We identified two distinct OCP subsets: Ly6C^hiCD11b^hi inflammatory OCPs (iOCPs) induced during chronic inflammation, and homeostatic Ly6C^hiCD11b^lo OCPs (hOCPs) which remained unchanged. Functional and proteomic characterization revealed that while iOCPs were rare and displayed low osteoclastogenic potential under normal conditions, they expanded during chronic inflammation and generated OCs with enhanced activity. In contrast, hOCPs were abundant and manifested high osteoclastogenic potential under normal conditions but generated OCs with low activity and were unresponsive to the inflammatory environment. Osteoclasts derived from iOCPs expressed higher levels of resorptive and metabolic proteins than those generated from hOCPs, highlighting that different osteoclast populations are formed by distinct precursors. We further identified the TNF-α and S100A8/A9 proteins as key regulators that control the iOCP response during chronic inflammation. Furthermore, we demonstrated that the response of iOCPs but not that of hOCPs was abrogated in tnf-α ^−/− mice, in correlation with attenuated IBL. Our findings suggest a central role for iOCPs in IBL induction. iOCPs can serve as potential biomarkers for IBL detection and possibly as new therapeutic targets to combat IBL in a wide range of inflammatory conditions.

References

[1] Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: protective and destructive roles. Periodontology 2000, 2010, 52: 163-206

[2] Fransson C et al. Severity and pattern of peri-implantitis-associated bone loss. J. Clin. Periodontol., 2010, 37: 442-448

[3] Cobelli N, Scharf B, Crisi GM, Hardin J, Santambrogio L. Mediators of the inflammatory response to joint replacement devices. Nat. Rev. Rheumatol., 2011, 7: 600-608

[4] Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat. Rev. Rheumatol., 2012, 8: 656-664

[5] Zhuang J et al. Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. PLoS One, 2012, 7: e48871

[6] Sawant A et al. Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer. Cancer Res., 2013, 73: 672-682

[7] Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Investig., 2006, 116: 1186-1194

[8] Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann. Intern. Med., 2000, 133: 795-799

[9] Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology, 2003, 124: 795-841

[10] van Staa TP et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology, 2003, 125: 1591-1597

[11] Aliprantis, A. O., Charles, J. F., & Nakamura, M. C. Osteoimmunology 2nd edn (eds Lorenzo, J., Horowitz, M. C., Choi, Y., Takayanagi, H., & Schett, G.) Ch. 2 (Academic Press, 2016).

[12] Meirow Y, Kanterman J, Baniyash M. Paving the road to tumor development and spreading: myeloid-derived suppressor cells are ruling the fate. Front. Immunol., 2015, 6: 523

[13] Bronstein-Sitton N et al. Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function. Nat. Immunol., 2003, 4: 957-964

[14] Ezernitchi AV et al. TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J. Immunol., 2006, 177: 4763-4772

[15] Vaknin I et al. A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression. Blood, 2008, 111: 1437-1447

[16] Charles JF et al. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J. Clin. Investig., 2012, 122: 4592-4605

[17] Yao Z et al. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J. Biol. Chem., 2006, 281: 11846-11855

[18] Hettinger J et al. Origin of monocytes and macrophages in a committed progenitor. Nat. Immunol., 2013, 14: 821-830

[19] Wolf Y et al. Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation. J. Exp. Med., 2017, 214: 905-917

[20] Sade-Feldman M et al. Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity, 2013, 38: 541-554

[21] Keffer J et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J., 1991, 10: 4025-4031

[22] Ish-Shalom E et al. Impaired SNX9 expression in immune cells during chronic inflammation: prognostic and diagnostic implications. J. Immunol., 2016, 196: 156-167

[23] Mooney CJ, Cunningham A, Tsapogas P, Toellner KM, Brown G. Selective expression of Flt3 within the mouse hematopoietic stem cell compartment. Int. J. Mol. Sci., 2017, 18: 1037

[24] Speziani C et al. Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur. J. Immunol., 2007, 37: 747-757

[25] Maitra R et al. Dendritic cell-mediated in vivo bone resorption. J. Immunol., 2010, 185: 1485-1491

[26] Ishii M et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature, 2009, 458: 524-528

[27] Muto A et al. Lineage-committed osteoclast precursors circulate in blood and settle down into bone. J. Bone Min. Res., 2011, 26: 2978-2990

[28] Jacome-Galarza CE, Lee SK, Lorenzo JA, Aguila HL. Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery. J. Bone Min. Res., 2013, 28: 1203-1213

[29] Slaney CY, Toker A, La Flamme A, Backstrom BT, Harper JL. Naive blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunity. Immunol. Cell Biol., 2011, 89: 7-13

[30] Kwak T et al. Distinct populations of immune-suppressive macrophages differentiate from monocytic myeloid-derived suppressor cells in cancer. Cell Rep., 2020, 33: 108571

[31] Madel MB, Ibanez L, Rouleau M, Wakkach A, Blin-Wakkach C. A novel reliable and efficient procedure for purification of mature osteoclasts allowing functional assays in mouse cells. Front. Immunol., 2018, 9: 2567

[32] Zhu S et al. Ovariectomy-induced bone loss in TNFalpha and IL6 gene knockout mice is regulated by different mechanisms. J. Mol. Endocrinol., 2018, 60: 185-198

[33] Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL. Identification of multiple osteoclast precursor populations in murine bone marrow. J. Bone Min. Res., 2006, 21: 67-77

[34] de Vries TJ, Schoenmaker T, Hooibrink B, Leenen PJ, Everts V. Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts. J. Leukoc. Biol., 2009, 85: 919-927

[35] Park-Min KH et al. Negative regulation of osteoclast precursor differentiation by CD11b and beta2 integrin-B-cell lymphoma 6 signaling. J. Bone Min. Res., 2013, 28: 135-149

[36] Miyamoto T et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood, 2001, 98: 2544-2554

[37] Servet-Delprat C et al. Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol., 2002, 3: 15

[38] Odvina CV et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J. Clin. Endocrinol. Metab., 2005, 90: 1294-1301

[39] Bone HG et al. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J. Clin. Endocrinol. Metab., 2011, 96: 972-980

[40] Smoum R et al. Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc. Natl. Acad. Sci. USA, 2010, 107: 17710-17715

[41] Rozdzial MM, Kubo RT, Turner SL, Finkel TH. Developmental regulation of the TCR zeta-chain. Differential expression and tyrosine phosphorylation of the TCR zeta-chain in resting immature and mature T lymphocytes. J. Immunol., 1994, 153: 1563-1580

[42] Takeshita S, Kaji K, Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Min. Res., 2000, 15: 1477-1488

[43] Yang Y et al. A modified tape transfer approach for rapidly preparing high-quality cryosections of undecalcified adult rodent bones. J. Orthop. Transl., 2021, 26: 92-100

[44] Muller T et al. Automated sample preparation with SP3 for low-input clinical proteomics. Mol. Syst. Biol., 2020, 16: e9111

[45] Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc., 2016, 11: 2301-2319

[46] Tyanova S et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods, 2016, 13: 731-740

[47] R-Core-Team, R: a language and environment for statistical computing.. R Foundation for Statistical Computing, Vienna, Austria. (2018). https://www.R-project.org/.

[48] Huber W et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods, 2015, 12: 115-121

[49] Ritchie ME et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 2015, 43: e47

[50] Deutsch EW et al. The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition. Nucleic Acids Res., 2017, 45: D1100-D1106

[51] Perez-Riverol Y et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res., 2019, 47: D442-D450